Actemra is an interleukin inhibitor. It binds to IL-6 receptors and inhibits their signaling.
From Actemra tocilizumab active and combined with methotrexate is used in the treatment of rheumatoid arthritis, juvenile idiopathic idiopathic arthritis, juvenile treatment of polyarticular idopathic arthritis and treatment of giant arteritis.
The mode of administration of Actemra is by solution for intravenous infusion and injection, solution by subcutaneous route.
Actemra is contraindicated with hypersensitivity, severe infections, latent tuberculosis, renal failure, liver failure.
Especially tell your doctor if you are taking other medications to treat your rheumatoid arthritis. You should not take etanercept (Enbrel®), adalimumab (Humira®), infliximab (Remicade®), rituximab (Rituxan®), abatacept (Orencia®), anakinra (Kineret®), certolizumab (Cimzia®) or golimumab (Simponi®) ), while receiving ACTEMRA. Receiving ACTEMRA with these medications can increase your risk of infection.
Actemra is contraindicated during pregnancy, lactation and alcohol consumption.
Actemra can have side effects such as: pneumonia, dizziness, dyspnea, cough, diarrhea, conjunctivitis, herpes, etc.
Actemra with active ingredient tocilizumab is marketed in other countries such as Spain, France, Germany, Italy, under the name of Roactemra and concentrate for 20 mg / ml infusion solution and prefilled injection solution with 162 mg syringe.
Video credits to Medicines/Diseases YouTube channel